Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Recurrent giant cell tumor of long bones: analysis of surgical management.

Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH.

Clin Orthop Relat Res. 2011 Apr;469(4):1181-7. doi: 10.1007/s11999-010-1560-9. Epub 2010 Sep 16.

2.

Giant cell tumor of bone: risk factors for recurrence.

Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH.

Clin Orthop Relat Res. 2011 Feb;469(2):591-9. doi: 10.1007/s11999-010-1501-7. Epub 2010 Aug 13.

3.

Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.

Arbeitsgemeinschaft Knochentumoren, Becker WT, Dohle J, Bernd L, Braun A, Cserhati M, Enderle A, Hovy L, Matejovsky Z, Szendroi M, Trieb K, Tunn PU.

J Bone Joint Surg Am. 2008 May;90(5):1060-7. doi: 10.2106/JBJS.D.02771.

PMID:
18451399
4.

Supplemental Bone Grafting in Giant Cell Tumor of the Extremity Reduces Nononcologic Complications.

Benevenia J, Rivero SM, Moore J, Ippolito JA, Siegerman DA, Beebe KS, Patterson FR.

Clin Orthop Relat Res. 2017 Mar;475(3):776-783. doi: 10.1007/s11999-016-4755-x.

PMID:
26932739
5.

Giant cell tumor with pathologic fracture: should we curette or resect?

van der Heijden L, Dijkstra PD, Campanacci DA, Gibbons CL, van de Sande MA.

Clin Orthop Relat Res. 2013 Mar;471(3):820-9. doi: 10.1007/s11999-012-2546-6. Erratum in: Clin Orthop Relat Res. 2012 Dec;470(12):3626.

6.

Soft tissue extension increases the risk of local recurrence after curettage with adjuvants for giant-cell tumor of the long bones.

van der Heijden L, van de Sande MA, Dijkstra PD.

Acta Orthop. 2012 Aug;83(4):401-5. doi: 10.3109/17453674.2012.711193. Epub 2012 Aug 10.

7.

[Clinical observation of surgical management for recurrent giant cell tumor of bone].

Kong Q, Yang J, Xing R, Tu C, Zhou Y, Zhang H, Duan H.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2013 Jan;27(1):36-40. Chinese.

PMID:
23427489
8.

The outcome of surgical treatment for recurrent giant cell tumor in the appendicular skeleton.

Wan R, Zhang W, Xu J, Hao P, Yang Y, Shen Y, Ding X, Qiu S.

J Orthop Sci. 2012 Jul;17(4):464-9. doi: 10.1007/s00776-012-0228-6. Epub 2012 Apr 17.

PMID:
22526715
9.

Treatment options for recurrent giant cell tumors of bone.

Balke M, Ahrens H, Streitbuerger A, Koehler G, Winkelmann W, Gosheger G, Hardes J.

J Cancer Res Clin Oncol. 2009 Jan;135(1):149-58. doi: 10.1007/s00432-008-0427-x. Epub 2008 Jun 3.

PMID:
18521629
10.

What Happens to the Articular Surface After Curettage for Epiphyseal Chondroblastoma? A Report on Functional Results, Arthritis, and Arthroplasty.

Farfalli GL, Slullitel PA, Muscolo DL, Ayerza MA, Aponte-Tinao LA.

Clin Orthop Relat Res. 2017 Mar;475(3):760-766. doi: 10.1007/s11999-016-4715-5.

PMID:
26831477
11.

Giant-cell tumor of the distal forearm.

Harness NG, Mankin HJ.

J Hand Surg Am. 2004 Mar;29(2):188-93.

PMID:
15043887
12.

Results of cement versus bone graft reconstruction after intralesional curettage of bone tumors in the skeletally immature patient.

Wallace MT, Henshaw RM.

J Pediatr Orthop. 2014 Jan;34(1):92-100. doi: 10.1097/BPO.0b013e31829b2f61.

PMID:
23812148
13.

Intralesional excision versus wide resection for giant cell tumor involving the acetabulum: which is better?

Guo W, Sun X, Zang J, Qu H.

Clin Orthop Relat Res. 2012 Apr;470(4):1213-20. doi: 10.1007/s11999-011-2190-6. Epub 2011 Nov 29.

14.

Factors of local recurrence of giant cell tumor of long bone after treatment: plain radiographs, pathology and surgical procedures.

Chanchairujira K, Jiranantanakorn T, Phimolsarnti R, Asavamongkolkul A, Waikakul S.

J Med Assoc Thai. 2011 Oct;94(10):1230-7.

PMID:
22145509
15.

Is intralesional treatment of giant cell tumor of the distal radius comparable to resection with respect to local control and functional outcome?

Wysocki RW, Soni E, Virkus WW, Scarborough MT, Leurgans SE, Gitelis S.

Clin Orthop Relat Res. 2015 Feb;473(2):706-15. doi: 10.1007/s11999-014-4054-3. Epub 2014 Dec 4.

16.

Effect of adjuvant therapies on recurrence in aneurysmal bone cysts.

Keçeci B, Küçük L, Isayev A, Sabah D.

Acta Orthop Traumatol Turc. 2014;48(5):500-6. doi: 10.3944/AOTT.2014.14.0020.

17.

Joint preservation after extensive curettage of knee giant cell tumors.

Ayerza MA, Aponte-Tinao LA, Farfalli GL, Restrepo CA, Muscolo DL.

Clin Orthop Relat Res. 2009 Nov;467(11):2845-51. doi: 10.1007/s11999-009-0913-8. Epub 2009 Jun 10.

18.

Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.

Li D, Zhang J, Li Y, Xia J, Yang Y, Ren M, Liao Y, Yu S, Li X, Shen Y, Zhang Y, Yang Z.

World J Surg Oncol. 2016 Apr 19;14:114. doi: 10.1186/s12957-016-0871-z.

19.

[Giant cell tumor of bone. An evaluation of 87 patients].

Tunn PU, Schlag PM.

Z Orthop Ihre Grenzgeb. 2003 Nov-Dec;141(6):690-8. German.

PMID:
14679436
20.

Supplemental Content

Support Center